奥扎莫德是一种有效的选择性 S1P1 和 S1P5 受体激动剂,在[35S]-GTPγS 结合实验中,EC50 分别为 410±160 pM 和 11±4.3 nM,是一种研究性免疫调节药物,目前正处于治疗复发性多发性硬化症(RMS)和溃疡性结肠炎(UC)的III期临床试验。它作为一个鞘氨醇-1-磷酸(S1P)受体激动剂,隔离淋巴细胞到外周淋巴器官和远离其慢性炎症部位。

清空选项
1306763-57-4 (S)-1-Amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride
BD2098411306763-57-498+%
¥938.00250mg常备现货
86864-60-0 (2-Bromoethoxy)(tert-butyl)dimethylsilane
BD4414386864-60-096%
¥28.005g常备现货
15115-60-3 4-Bromo-1-indanone
BD1154915115-60-398%
¥31.005g常备现货
60899-34-5 1-Oxo-2,3-dihydro-1H-indene-4-carbonitrile
BD4185360899-34-597%
¥299.005g常备现货
258273-31-3 3-Cyano-4-isopropoxybenzoic acid
BD86281258273-31-398%
¥170.0010g常备现货
1306763-31-4 (S)-1-(Boc-amino)-2,3-dihydro-1H-indene-4-carbonitrile
BD008162461306763-31-495%
¥334.001g常备现货
1306763-61-0 (S)-tert-Butyl (2-((tert-butyldimethylsilyl)oxy)ethyl)(4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate
BD7492881306763-61-097%
¥19206.005g
1